DOCSLIB.ORG

BARDA Industry Day 2020 Participant List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BARDA Industry Day 2020 Participant List BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization Sana Abidi M.A. Pii Teresa Abraham Ph.D. Visby Medical Sam Abrams M.P.H. Sr. Specialist Public Health APHL Preparedness and Response Carl Accettura Managing Director Global Pharma Consulting LLC Otuo Acheampong Senior Business Consultant BARDA/OD Nathan Adams Ph.D. DTRA / RD‐CBA Peter Adams Ph.D. Health Scientist IEIDD BARDA/IEIDD Anna Adams Ph.D. Eurofins ARCA Ed Addison Ph.D. Cloud Pharmaceuticals Lonnie Adelman B.S. CEO and Founder Iassay Inc. Sabrina Aery B.A. WWVAP&HEOR Special Prjt Lead Bristol Myers Squibb Richard Agans Ph.D. Dr. Parsons/NAMRU‐D Deepak aggarwal M.P.H. FDA David Aglow B.S. Program Manager BARDA/PCI Heidi Agostini Ph.D. Chief Operating Officer Sequoia Consulting Group LLC Aaron Aguinaga B.S. A&C Scientific Demir Akin D.V.M, Deputy Director Stanford University School Of Medicine Ph.D. Hansilla Alaigh Director Emergent Biosolutions Mark Albrecht Ph.D. Health Scientist BARDA/CBRN Matt Aldag Ph.D. Booz Allen Hamilton Jennifer Aldrich M.A. National Marrow Donor Program (NMDP)/Radiation Injury Treatment Network Brian Alexander J.D. PRA Health Sciences David Alexander Ph.D. Dir Business Strategy Ontera Stephen Alexander B.S. Business Development Biomojo LLC Kendra Alfson Ph.D. Scientific Support Manager Texas Biomedical Research Institute Aminata Alharazim M.S. Project Officer PCI BARDA/PCI Melissa Allard B.A. Associate Director AMRI Kenneth Allen B.S. CEO Cyvernetics Corporation Nate Allera B.S. Business Development Associate Maximus Isaf Al‐Nabulsi Program Manger DOE Meghan Alonso M.B.A. Director Business Development Covance Tolga Alpugan M.B.A. Emergent Biosolutions Inc. Page 1 of 65 BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization Jennifer Alton M.P.P. Pathway Policy Group randi altschul CEO Pop Test Oncology Llc/Palisades Therapeutics Randice Altschul CEO Pop Test Oncology LLC/Palisades Therapeutics Janet Alvanzo Contract Specialist BARDA/DCMA Annie Alvis M.B.A. Chief Operating Officer Volumetrix Ibiba Amachree Contract Specialist BARDA/DCMA Javad Aman Ph.D. Integrated Biotherapeutics Kathryn Amass Health Scientist BARDA/DCD Kensay Amaya Biologist BARDA/CBRN Sasan Amini Ph.D. CEO Clear Labs Vasudev Anand ADME SME BARDA/CBRN Brett Anderson Ph.D. Program Manager Humanetics Corporation Lisa Anderson Ph.D. Director of Education and Training Sepsis Alliance Devon Andres Biologist BARDA/CBRN Vickey Andrews B.A. President Andrews Aviation LLC. Bria Andrews B.S. ASPR/BARDA Michael Angelastro B.S. Director PCI BARDA/PCI James Anthony Biologist BARDA/DDDI Peter Antinozzi Ph.D. Argentum Medical Eila Arich‐Landkof M.A. Oriel Research Therapeutics Kimberly Armstrong Ph.D. Branch Chief IEIDD BARDA/IEIDD Frank Arnold Senior Vaccine and Biologic BARDA/IEIDD Development Analyst Samuel Arsenault M.S. FDA Phyllis Arthur M.B.A. VP Infectious Diseases and BIO Diagnostics Policy Ericka Artz M.S. Senior Exercise Planner Joint Staff Joint Requirements Office For CBRN Defense Anu Arya Ph.D. Arietis Ava Asgari B.A. Plug And Play Jason Asher Ph.D. Senior Quantitative Analyst BARDA Viqar Aslam B.S. IBBR Michael Astwood M.S. President/CEO ASRT Inc. Ercem (Aerjem) Atillasoy M.D. Chief Regulatory and Safety Officer Allovir Inc. Page 2 of 65 BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization Arthur Atkins Management Analyst BARDA/DDDI Trey Atkins Drew Pharmaceutical Ronald Atkinson M.B.A. Program Manager Mapp Biopharmaceuticals Gregory Auner Ph.D. CTO Seraph Biosciences Simon Authier D.V.M Director Charles River Chloe Autran Business development manager Prolacta Bioscience Franco Aveau M.A. Senior Program Analyst BARDA/CBRN Julianne Averill M.S. CFO Alveo Technologies Jim Axtelle Chromologic Ana Ayala J.D. Senior Global Health Officer HHS/OGA Milad Babaei Mr. Nab Biosciences Inc. Tahar Babas Ph.D. Biologist OS/ASPR/BARDA Judith Bader M.D. Contractor Rad/Nuc BARDA/CBRN Christopher Badorrek Ph.D. JPEO CBRND CBRN M Anne Bailey PharmD Emerging Tech Clinical Specialist Veterans Health Administration Denise Baken Ph.D. President Shield Analysis Technology LLC Brett Baker President Microbion Corporation Bob Balcerzak M.B.A. CEO Allotropic Jennifer Baldwin M.B.A. Talis Biomedical Jacob Ball Health statistician US Army Public Health Center Victor Balladares Engineer Director of Production and Design Overview.Corp Ralph Balsamo M.P.A Program Analyst BARDA/OD Aaron Bandremer M.S. Biologist BARDA/IEIDD Lyn Baranowski M.B.A. Chief Operating Officer Altavant Sciences Maria Barbosa Ph.D. Chief Executive Officer Conquerab Inc. Alec Barclay B.S. Chief Operations Officer T2 Biosystems Julio Barrera‐Oro Ph.D. Health Scientist BARDA/CBRN Troy Barring President TAB Consulting LLC Elizabeth Barrows Ms. Aardvark Medical Bill Barry M.P.H. WHB Consulting Salem Barry Contract Specialist BARDA/DCMA William Barry Biofire Defense Bill Basinger M.S. CEO Countervail Corporation Page 3 of 65 BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization Gail Bassette M.A. Program Coordinator MBDA FPC Ramin Bastani B.A. CEO Healthvana Inc. Shelsy Bastedo Regional Emergency Coordinator ASPR Subhendu Basu Ph.D. COO Adaptive Phage Therapeutics Matthew Bateman M.B.A. Versiv Thalansh Batra B.S. Chief Executive Officer Pareto Tree Bruce Batten Ph.D. CSO GRIP Molecular Technologies Bruno Battistini Ph.D. Chief Clinical & Gov Affairs Officer Www.Pulmonem.Ca Jonathan Baut CEO Gabi Smartcare Tito Bautista B.S. President JETS Inc Swapnil Bawage Ph.D. Georgia Institute Of Technology Stacy Baxter M.A. Director of Business Development Potomacwave Andy Bean Ph.D. Dr CSIRO Mollie Beaver National Sales Director Federal Accounts Siemens Healthineers Sharon Beck B.S. Director of Client Services Goldbelt C6 Thomas Beck Sc.D. Principle Consultant Awe Technologies LLC Jen Beedon M.B.A. Cytovale Gavi Begtrup Ph.D. Founder/Principal Polymath Strategies LLC Aynun Begum Ph.D. CEO Neyroblastgx LLC Craig Behnke Ph.D. SVP Production and Development Lumen Bioscience Eleni Belesi D.V.M European Commission Kathryn Bell B.A. Senate HELP Committee Lauren Bell M.S. ASPR Jerry Bell Ph.D. Managing Partner Assured Performance Systems Inc Mika Bellamy M.S. Senior Director MPF Luca Bellosta B.S. Politecnico Di Milano Timothy Belski Biologist BARDA/PCI Amy Belton Biologist BARDA/OD Kambez Benam Assistant Professor University Of Colorado Anschutz Medical Campus Joffrey Benford M.B.A. Director DCMA BARDA/DCMA Kirsten Benjamin Ph.D. Vice President Amyris Morgan Benner M.P.H. ASPR Astrid Benson B.S. Director of Program Operations Plug And Play Tech Center Page 4 of 65 BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization John Beresny M.B.A. SVP Digital Infuzion Inc. Yngvar Berg M.B.A. Algipharma Mitchell Berger M.P.H. Public Health Advisor HH Peter Berglund Ph.D. CTO HDT Bio Julie Bergmann Health Scientists BARDA/CBRN Gail Berman M.D. VP Medical and Scientific Strategy Paratek Jody Berry Vice President R&D Orasure Technologies Inc. Breena Berte MSS MEd Assistant Program Manager JPEO‐CBRND Ronald Bertin M.S. Integrated Project Management Inc. Bryan Berube Ph.D. Senior Scientist HDT Bio Corp. Terry Besch D.V.M Nonclinical Advisor LMI Shelly Beschta RN Infection Preventionist REEDSBURG AREA MEDICAL CENTER Phillip Beske Ph.D. Principal Research Scientist Battelle Cameron Bess Biologist BARDA/CBRN Venkaiah Betapudi Ph.D. Research Scientist Department Of Homeland Security Barkur Bhat Ph.D. Senior Regulatory Affairs Manager JPEO‐CBRNM And ONE‐RAQA Himanshu Bhatia Founder & CEO RICOVR Healthcare Inc RAJENDRA BHATNAGAR Ph.D. President/CSO Moleculardecoys Inc Anshda Bhatnagar B.S. Biomedical Science Coventry University Rajesh Bhutani None Gregory Bice M.B.A. Vice President GAP Solutions Laszlo Bicskei M.S. Mitochon Technologies LLC Catherine Bigger Ph.D. Scientist LMI CTR Supporting JPEO‐ JPEO‐CBRN‐Medical CBRN‐Medical Gary Bigler Air To All Inc. Pamuk Bilsel Ph.D. Flugen Gary Binyamin Ph.D. Slate Therapeutics Inc. Matthew Bio Ph.D. President & CEO Snapdragon Chemistry Inc John Birkmire M.S. Director BW Design Group Karen Biscardi M.S. Clinical Operations Dev Analyst BARDA/RQA Erica Bizzell Ph.D. AAAS STPF Fellow/Health Scientist NIH Paul Blackborow M.A. Photonics Management Corp John Blackington B.A. LIFESCIENCE LOGISTICS Eric Blair M.B.A. CCO Argonaut MS Page 5 of 65 BARDA INDUSTRY DAY 2020 | PARTICIPANT LIST th October 27 , 2020 | VIRTUAL EVENT First Name Last Name Degree Title Organization Gretta Blatner M.P.H. Special Assistant to the Director BARDA/OD Steven Bloom B.S. CEO Synterus Therapeutics Mike Blyth M.B.A. President STTH Henri Bodeau M.A. Crossject Neil Bodie D.V.M CEO Paradigm Immunotherapeutics Inc Hans Boehringer Ph.D. DCN Diagnostics Joseph Bogan Ph.D. Director Mriglobal John Bogdan Ph.D. Senior Consultant JPEO CRBRN Medical Dorothee Bond M.P.H. Senior Analyst ASPR Ludovic Bonnet Ph.D. Chemical Engineering Enesi Pharma Limited WENDY BOONE M.P.H. VP Operations WENDY E BOONE Brittany Boone IT Support Specialist BARDA/OD Philippe Bordeau M.S. Vice President Alaxia David Borhani Ph.D. Director Platform Ginkgo Bioworks Inc. Commercialization Pharma Oleg Borisov M.S. Project Officer BARDA/IEIDD Jarrod Borkat M.B.A. VP Corporate Strategy Emergent Biosolutions Zachary Bornholdt Ph.D. Senior Director Mapp Biopharmaceutical Inc. Aken Bosch Ph.D. CRM Testing BARDA/DRIVe Ellen Bosl M.S. Senior Director R&D 3M Michael Bosley M.S. President Goldbelt C6 LLC Donna Boston M.S. Project Officer BARDA/DRIVe David Boucher Ph.D. Health Scientist BARDA/CBRN Dave Bourke M.B.A. Program Manager Tunnell Government Services Inc. Casey Boutwell Ph.D.
Load more

Recommended publications
  • Annual Report
    Fiscal Year 2015 Annual Report To: Governor Charlie Baker Secretary of Administration and Finance Kristen Lepore Secretary of Housing & Economic Development Jay Ash Senate President Stan Rosenberg Speaker of the House Robert DeLeo State Comptroller Thomas G. Shack III Clerk of the Senate William Welch Clerk of the House of Representatives Steven James By forward: House and Senate Committees on Ways and Means and the Joint Committee on Economic Development and Emerging Technologies Date: September 30, 2015 Re: FY 2015 Annual Report of the Massachusetts Life Sciences Center The Massachusetts Life Sciences Center (MLSC) respectfully submits this Annual Report detailing the organization’s operations and accomplishments during Fiscal Year (FY) 2015. For the past seven years, the MLSC has led the state’s life sciences initiative – a $1 billion initiative designed to strengthen the state’s economy by accelerating the growth of our life sciences sectors in Massachusetts. The MLSC’s goal has been to make Massachusetts the strongest life sciences ecosystem in the world and the best place in the world for life sciences companies to do business. The MLSC collaborates with the private sector to accelerate the pace of innovation and economic development in all regions of Massachusetts. The MLSC’s strategy has been based on the belief that the best role for the state is to invest in Massachusetts’ innovation capacity – the ability to produce and commercialize a flow of innovative life sciences technologies over the long term. Since 2008, the MLSC has invested aggressively in five “enablers” that build innovation capacity: translational research, entrepreneurship, workforce development, infrastructure and collaboration.
    [Show full text]
  • View Annual Report
    GENOCEA BIOSCIENCES, INC. FORM 10-K (Annual Report) Filed 02/27/15 for the Period Ending 12/31/14 Address 100 ACORN PARK DRIVE CAMBRIDGE, MA 02140 Telephone 617-876-8191 CIK 0001457612 Symbol GNCA SIC Code 2836 - Biological Products, Except Diagnostic Substances Fiscal Year 12/31 http://www.edgar-online.com © Copyright 2015, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use. Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36289 Genocea Biosciences, Inc. (Exact name of registrant as specified in its charter) Delaware 51 -0596811 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 100 Acorn Park Drive Cambridge, Massachusetts 02140 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (617) 876-8191 Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on which Title of each class registered Common Stock, $0.001 par value NASDAQ Global Market Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
    [Show full text]
  • Annual Report
    HUMAN CAPITAL FISCAL YEAR 2019 ANNUAL REPORT INNOVATION CAPITAL GROWTH CAPITAL INTELLECTUAL CAPITAL The capital of scientific revolution. Fiscal Year 2019 Annual Report • Massachusetts Life Sciences Center • i BOARD OF DIRECTORS TABLE OF CONTENTS A LETTER FROM THE INTERIM PRESIDENT & CEO Michael J. Heffernan Co-Chair; Secretary, Executive Office for Administration & Finance A Letter from the President & CEO ...........................................................................................1 Mike Kennealy Co-Chair; Secretary, Executive Office Vision & Strategy: The Capital of Scientific Revolution ......................................................2 The Patients Are Waiting of Housing & Economic Development Fiscal Year 2019 Highlights and The Bottom Line ..............................................................3 Gary P. Kearney, MD Around the globe, billions of patients and their loved ones await advances in health President, Longwood Urological Associates Human Capital care that will produce the products, devices, and therapies to alleviate suffering, Marty Meehan Internship Challenge: Enhancing Career Exploration improve treatment, and save lives. Much of that attention falls on Massachusetts, as President, University of Massachusetts and Expanding the Talent Pipeline ............................................................................................4 the world looks to our ecosystem to deliver the breakthroughs that further unlock our Peter Parker understanding of human physiology, harness the power of data science,
    [Show full text]
  • Batman in the 50S Free
    FREE BATMAN IN THE 50S PDF Joe Samachson,Various,Edmond Hamilton,Bill Finger,Bob Kane,Dick Sprang,Stan Kaye,Sheldon Moldoff | 191 pages | 01 May 2002 | DC Comics | 9781563898105 | English | United States Batman in the Fifties (Collected) | DC Database | Fandom An instantly recognizable theme song, outrageous death traps, ingenious gadgets, an army of dastardly villains and femme fatales, and a pop-culture phenomenon unmatched for generations. James Bondright? When it first premiered inBatman was the most faithful adaptation of a bona fide comic book superhero ever seen on the screen. It was a nearly perfect blend of the Saturday matinee movie serials where most comic book characters had their first Hollywood break and the comics of its time. But the TV series, particularly during its genesis, was both a product of its own time, and that of an earlier era. Both Flash Gordon and Dick Tracy had made the leap to the big screen before Superman had even hit newsstands, and both saw their serial adventures get two sequels. While Flash Gordonparticularly the first one, was a faithful within the limitations of its budget translation of the Alex Raymond comic strips, Dick Tracy was less so. Years before Richard Donner and Christopher Reevethis one made audiences believe a man could fly, and featured a perfectly cast Tom Tyler in the title role, but was still rather beholden to serial storytelling conventions and the aforementioned budgetary limitations. Ad — content continues below. Batman and Robin are portrayed much as they are in the comics, despite some unfortunately cheap costumes, and less than physically convincing actors in the title roles.
    [Show full text]
  • Portrayals of Stuttering in Film, Television, and Comic Books
    The Visualization of the Twisted Tongue: Portrayals of Stuttering in Film, Television, and Comic Books JEFFREY K. JOHNSON HERE IS A WELL-ESTABLISHED TRADITION WITHIN THE ENTERTAINMENT and publishing industries of depicting mentally and physically challenged characters. While many of the early renderings were sideshowesque amusements or one-dimensional melodramas, numerous contemporary works have utilized characters with disabilities in well- rounded and nonstereotypical ways. Although it would appear that many in society have begun to demand more realistic portrayals of characters with physical and mental challenges, one impediment that is still often typified by coarse caricatures is that of stuttering. The speech impediment labeled stuttering is often used as a crude formulaic storytelling device that adheres to basic misconceptions about the condition. Stuttering is frequently used as visual shorthand to communicate humor, nervousness, weakness, or unheroic/villainous characters. Because almost all the monographs written about the por- trayals of disabilities in film and television fail to mention stuttering, the purpose of this article is to examine the basic categorical formulas used in depicting stuttering in the mainstream popular culture areas of film, television, and comic books.' Though the subject may seem minor or unimportant, it does in fact provide an outlet to observe the relationship between a physical condition and the popular conception of the mental and personality traits that accompany it. One widely accepted definition of stuttering is, "the interruption of the flow of speech by hesitations, prolongation of sounds and blockages sufficient to cause anxiety and impair verbal communication" (Carlisle 4). The Journal of Popular Culture, Vol. 41, No.
    [Show full text]
  • The Reflection of Sancho Panza in the Comic Book Sidekick De Don
    UNIVERSIDAD DE OVIEDO FACULTAD DE FILOSOFÍA Y LETRAS MEMORIA DE LICENCIATURA From Don Quixote to The Tick: The Reflection of Sancho Panza in the Comic Book Sidekick ____________ De Don Quijote a The Tick: El Reflejo de Sancho Panza en el sidekick del Cómic Autor: José Manuel Annacondia López Directora: Dra. María José Álvarez Faedo VºBº: Oviedo, 2012 To comic book creators of yesterday, today and tomorrow. The comics medium is a very specialized area of the Arts, home to many rare and talented blooms and flowering imaginations and it breaks my heart to see so many of our best and brightest bowing down to the same market pressures which drive lowest-common-denominator blockbuster movies and television cop shows. Let's see if we can call time on this trend by demanding and creating big, wild comics which stretch our imaginations. Let's make living breathing, sprawling adventures filled with mind-blowing images of things unseen on Earth. Let's make artefacts that are not faux-games or movies but something other, something so rare and strange it might as well be a window into another universe because that's what it is. [Grant Morrison, “Grant Morrison: Master & Commander” (2004: 2)] TABLE OF CONTENTS 1. Acknowledgements v 2. Introduction 1 3. Chapter I: Theoretical Background 6 4. Chapter II: The Nature of Comic Books 11 5. Chapter III: Heroes Defined 18 6. Chapter IV: Enter the Sidekick 30 7. Chapter V: Dark Knights of Sad Countenances 35 8. Chapter VI: Under Scrutiny 53 9. Chapter VII: Evolve or Die 67 10.
    [Show full text]
  • Science-USA (Boston+), November 2012
    Schweizerische Eidgenossenschaft Confédération suisse Confederazione Svizzera Confederaziun svizra Science-USA (Boston+), November 2012 Table of Contents 1. Policy ........................................................................................................................................................................................ 1 2. Education .................................................................................................................................................................................. 2 3. Life Science .............................................................................................................................................................................. 3 4. Nano / Micro Technology / Material Science ............................................................................................................................. 4 5. Information & Communications Technology ............................................................................................................................. 6 6. Energy / Environment ............................................................................................................................................................... 6 7. Engineering / Robotics / Space ................................................................................................................................................. 8 8. Physics / Chemistry / Math ......................................................................................................................................................
    [Show full text]
  • By JOHN WELLS a M E R I C a N C H R O N I C L E S
    AMERICAN CHRONICLES THE 1965-1969 by JOHN WELLS Table of Contents Introductory Note about the Chronological Structure of American Comic Book Chronicles ................. 4 Note on Comic Book Sales and Circulation Data.......................................... 5 Introduction & Acknowledgements ............ 6 Chapter One: 1965 Perception................................................................8 Chapter Two: 1966 Caped.Crusaders,.Masked.Invaders.............. 69 Chapter Three: 1967 After.The.Gold.Rush.........................................146 Chapter Four: 1968 A.Hazy.Shade.of.Winter.................................190 Chapter Five: 1969 Bad.Moon.Rising..............................................232 Works Cited ...................................................... 276 Index .................................................................. 285 Perception Comics, the March 18, 1965, edition of Newsweek declared, were “no laughing matter.” However trite the headline may have been even then, it wasn’t really wrong. In the span of five years, the balance of power in the comic book field had changed dramatically. Industry leader Dell had fallen out of favor thanks to a 1962 split with client Western Publications that resulted in the latter producing comics for themselves—much of it licensed properties—as the widely-respected Gold Key Comics. The stuffily-named National Periodical Publications—later better known as DC Comics—had seized the number one spot for itself al- though its flagship Superman title could only claim the honor of
    [Show full text]
  • LIVIO VALENTI CV 2011-Present VAXESS TECHNOLOGIES, INC
    LIVIO VALENTI CV Livio Valenti is the co-founder of Vaxess Technologies and Giorgio Ruffolo Research Fellow in the Sustainability Science Program at Harvard Kennedy School of Government and the Harvard Global Health Institute. He received a Master in Public Policy from Harvard’s Kennedy School of Government in 2013, where he was the recipient of the Empedocle Maffia Fellowship provided by the Italian Government to one outstanding individual to attend Harvard. While a student at Harvard, he co-founded Vaxess Technologies, an innovative life sciences company that aims to create vaccines that do not need refrigeration. Vaxess has raised $4.75m in venture capital, angel investors, and various public institutions, including the Massachusetts Life Science Center (MLSC). Harvard Business School (HBS) published a case on Vaxess in 2014. Livio was named by Forbes one of the 30 under 30 individuals likely to change the world for his commitment in improving global health and one of the 10 under 40 (PrimiDieci-Under40 2014) most distinguished individuals with Italian origins or Italian nationality currently in the USA by the Italian-American Chamber of Commerce and the Italian Ministry of Foreign Affairs. His academic research at Harvard focuses on the space at the intersection between Government and Business. Livio is researching the potential to sustainably commercialize innovative technologies to improve global health. He is contributing to collaborative work with the Initiative on Innovation and Access to Technologies for Sustainable Development led by William Clark. Professional experience Prior to studying at Harvard, Livio worked for the United Nations in several developing countries. His work included advising government clients and international financing institutions in the identification, appraisal and financing of large investment projects.
    [Show full text]
  • Comic Book Collection
    2008 preview: fre comic book day 1 3x3 Eyes:Curse of the Gesu 1 76 1 76 4 76 2 76 3 Action Comics 694/40 Action Comics 687 Action Comics 4 Action Comics 7 Advent Rising: Rock the Planet 1 Aftertime: Warrior Nun Dei 1 Agents of Atlas 3 All-New X-Men 2 All-Star Superman 1 amaze ink peepshow 1 Ame-Comi Girls 4 Ame-Comi Girls 2 Ame-Comi Girls 3 Ame-Comi Girls 6 Ame-Comi Girls 8 Ame-Comi Girls 4 Amethyst: Princess of Gemworld 9 Angel and the Ape 1 Angel and the Ape 2 Ant 9 Arak, Son of Thunder 27 Arak, Son of Thunder 33 Arak, Son of Thunder 26 Arana 4 Arana: The Heart of the Spider 1 Arana: The Heart of the Spider 5 Archer & Armstrong 20 Archer & Armstrong 15 Aria 1 Aria 3 Aria 2 Arrow Anthology 1 Arrowsmith 4 Arrowsmith 3 Ascension 11 Ashen Victor 3 Astonish Comics (FCBD) Asylum 6 Asylum 5 Asylum 3 Asylum 11 Asylum 1 Athena Inc. The Beginning 1 Atlas 1 Atomic Toybox 1 Atomika 1 Atomika 3 Atomika 4 Atomika 2 Avengers Academy: Fear Itself 18 Avengers: Unplugged 6 Avengers: Unplugged 4 Azrael 4 Azrael 2 Azrael 2 Badrock and Company 3 Badrock and Company 4 Badrock and Company 5 Bastard Samurai 1 Batman: Shadow of the Bat 27 Batman: Shadow of the Bat 28 Batman:Shadow of the Bat 30 Big Bruisers 1 Bionicle 22 Bionicle 20 Black Terror 2 Blade of the Immortal 3 Blade of the Immortal unknown Bleeding Cool (FCBD) Bloodfire 9 bloodfire 9 Bloodshot 2 Bloodshot 4 Bloodshot 31 bloodshot 9 bloodshot 4 bloodshot 6 bloodshot 15 Brath 13 Brath 12 Brath 14 Brigade 13 Captain Marvel: Time Flies 4 Caravan Kidd 2 Caravan Kidd 1 Cat Claw 1 catfight 1 Children of
    [Show full text]
  • The Green Hornet
    1 THE GREEN HORNET SHATTERED MASK – PART 2 Written by Michael Jennings REVISION HISTORY: May 21, 2004 FIRST DRAFT July 18, 2004 SECOND DRAFT October 15, 2004 FINAL DRAFT ========================================================================================= DISCLAIMER ========================================================================================= “THE GREEN HORNET” is owned, (TM), and (c) by THE GREEN HORNET, INC. All rights reserved. This script was made without permission, approval, authorization, or endorsement. Any reproduction, duplication, or distribution of this material in any form is expressly prohibited. It is absolutely forbidden to use this script for commercial gain. This original story is based on “GREEN HORNET” characters created by GEORGE W. TRENDLE and the “GREEN HORNET” television series created by WILLIAM DOZIER. All original characters, story ideas, and events were created by the author and cannot be duplicated or edited without the author’s permission. CONDITIONS OF USE: (1) Do not alter this content of this file. (2) Leave all disclaimers in tact for legal purposes. (3) Provide a link back to the site where this file originated. You may contact the writer of this script at [email protected]. 2 ACT I FADE IN. INT. BRITT REID’S APARTMENT (STOCK) - GARAGE THE GREEN HORNET and KATO bring up the BLACK BEAUTY from the basement of Britt’s garage. Both heroes enter the vehicle. CUT TO: INT. BLACK BEAUTY CLOSE ON: GREEN HORNET Seated in the back seat of the Black Beauty, the Hornet says to Kato -- GREEN HORNET Check the scanner. CLOSE ON: INSTRUMENT PANEL Kato’s gloved hand pulls back the console between the driver and passenger seats to reveal a set of buttons and switches.
    [Show full text]
  • Superhero Origins As a Sentence Punctuation Exercise
    Superhero Origins as a Sentence Punctuation Exercise The Definition of a Comic Book Superhero A comic book super hero is a costumed fictional character having superhuman/extraordinary skills and has great concern for right over wrong. He or she lives in the present and acts to benefit all mankind over the forces of evil. Some examples of comic book superheroes include: Superman, Batman, Spiderman, Wonder Woman, and Plastic Man. Each has a characteristic costume which distinguishes them from everyday citizens. Likewise, all consistently exercise superhuman abilities for the safety and protection of society against the forces of evil. They ply their gifts in the present-contemporary environment in which they exist. The Sentence Punctuation Assignment From earliest childhood to old age, the comics have influenced reading. Whether the Sunday comic strips or editions of Disney’s works, comic book art and narratives have been a reading catalyst. Indeed, they have played a huge role in entertaining people of all ages. However, their vocabulary, sentence structure, and overall appropriateness as a reading resource is often in doubt. Though at times too “graphic” for youth or too “childish” for adults, their use as an educational resource has merit. Such is the case with the following exercise. Superheroes as a sentence punctuation learning toll. Among the most popular of comic book heroes is Superman. His origin and super-human feats have thrilled comic book readers, theater goers, and television watchers for decades. However, many other comic book superheroes exist. Select one from those superhero origin accounts which follow and compose a four paragraph superhero origin one page double-spaced narative of your selection.
    [Show full text]